2005 Miami Breast Cancer Conference
Posters
1. Cancer Trials Support Unit and Central Institutional Review Board 2. Controversies in HER2 Testing 3. Chemoprevention and Management of DCIS 4. Neoadjuvant Chemotherapy 5. Neoadjuvant Endocrine Therapy 6. Neoadjuvant Trials of Trastuzumab in HER2-Positive Breast Cancer 7. Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trial 8. Sequential Adjuvant Hormonal Therapy Following Tamoxifen 9. Adjuvant Endocrine Therapy Trials in Premenopausal Patients 10. Research To Practice: Adjuvant Endocrine Therapy 11. Optimizing Adjuvant Chemotherapy: Ongoing Trials and Recent Results 12. CALGB-49907: Adjuvant Chemotherapy in Elderly Women 13. Clinical Trials of Adjuvant Trastuzumab 14. Trials of Hormonal Therapy in Metastatic Disease 15. Sequencing of Hormonal Therapies in Metastatic Disease 16. Patient Perspectives on Endocrine Therapy for Metastatic Disease 17. Chemotherapy for Metastatic Disease 18. Research To Practice: Chemotherapy in Metastatic Disease 19. Targeting the HER Pathways 20. Research To Practice: HER2-Positive Disease 21. Partial Breast Irradiation for Primary Breast Cancer 22. Management of the Axilla 23. Antiangiogenic Therapy 24. Adjuvant Bisphosphonates 25. Predicting Prognosis in Women with Early Breast Cancer 26. Impact of CME on Practice Patterns in Breast Cancer
Download all